Attovia Therapeutics Inc.
ATTO | NASDAQ
$21.30
-$0.84 (-3.79%)
At close: Sep 21, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q1 2025 Mar 30, 2025 |
|---|---|---|---|
PE Ratio | -23.55 | -45.63 | -54.75 |
PEG Ratio | 3.77 | n/a | n/a |
PS Ratio | 2.22K | n/a | n/a |
PB Ratio | 8.87 | 6.36 | n/a |
P/FCF Ratio | -28.33 | -45.79 | -52.99 |
P/OCF Ratio | -28.62 | -46.51 | -59.71 |
OCF/S Ratio | -3.73K | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.04 | n/a |
Quick Ratio | 9.39 | 13.94 | n/a |
Current Ratio | 9.39 | 13.94 | n/a |
Asset Turnover | 0 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a |
Return on Equity | -18.34% | -14.06% | n/a |
Return on Assets | -16.12% | -12.77% | n/a |
Return on Invested Capital | -18.51% | -14.43% | n/a |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | 45.33% | n/a | n/a |
Net Profit Margin | -4.6K% | n/a | n/a |
Pretax Profit Margin | -4.6K% | n/a | n/a |
Operating Profit Margin | -4.85K% | n/a | n/a |
FCF Margin | -3.75K% | n/a | n/a |
EBITDA Margin | -4.79K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ATTO